0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Dermatology | 
Case Report/Case Series |  ONLINE FIRST
Christoph T. Ellebrecht, MD; Eun J. Choi, BS; David M. Allman, PhD; et al.
JAMA Dermatol. Published online August 13, 2014. doi:10.1001/jamadermatol.2014.1939
Includes: Supplemental Content

JAMA Dermatology | 
Case Report/Case Series |  ONLINE FIRST
Tomoko Nakahara, MD; Atsushi Takagi, MD, PhD; Jun Yamagami, MD, PhD; et al.
JAMA Dermatol. Published online July 30, 2014. doi:10.1001/jamadermatol.2014.411
Includes: Supplemental Content

JAMA Dermatology | 
Original Investigation | 
Kara Heelan, MB, BCh, BAO, MRCPI; Faisal Al-Mohammedi, MD, FRCPC; Myles J. Smith, MB, BCh, BAO, FRCSI; et al.
JAMA Dermatol. 2014;150(7):703-708. doi:10.1001/jamadermatol.2013.6739.
Includes: Supplemental Content

JAMA Dermatology | 
JAMA Dermatology Patient Page |  FREE
Marcel F. Jonkman, MD, PhD
JAMA Dermatol. 2014;150(6):680. doi:10.1001/jamadermatol.2014.136.

JAMA Dermatology | 
Editorial | 
Dédée F. Murrell, MA, BMBCh, MD, FACD; Masayuki Amagai, MD; Victoria P. Werth, MD
JAMA Dermatol. 2014;150(3):245-247. doi:10.1001/jamadermatol.2013.8179.

JAMA Dermatology | 
Original Investigation | 
Ziba Rahbar, MD, MPH; Maryam Daneshpazhooh, MD; Mostafa Mirshams-Shahshahani, MD; et al.
JAMA Dermatol. 2014;150(3):266-272. doi:10.1001/jamadermatol.2013.8175.
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Shigeruko Iijima, MD; Takahiro Hamada, MD; Mirei Kanzaki, MD; et al.
JAMA Dermatol. 2014;150(1):97-99. doi:10.1001/jamadermatol.2013.5666.

JAMA Dermatology | 
Original Investigation | 
Deshan F. Sebaratnam, MBBS(Hons), MMed(Clin Epi); Anna Marie Hanna, MBBS; Shien-ning Chee, MBBS; et al.
JAMA Dermatol. 2013;149(10):1186-1191. doi:10.1001/jamadermatol.2013.4972.

JAMA Dermatology | 
Case Report/Case Series | 
Hiroshi Saruta, MD; Norito Ishii, MD; Kwesi Teye, PhD; et al.
JAMA Dermatol. 2013;149(10):1209-1213. doi:10.1001/jamadermatol.2013.5244.

JAMA Dermatology | 
Notable Notes | 
Meredith L. Orseth, BS, BA; Thomas G. Cropley, MD
JAMA Dermatol. 2013;149(10):1220. doi:10.1001/jamadermatol.2013.6880.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
Subcutaneous Veltuzumab, a Humanized Anti-CD20 Antibody, in the Treatment of Refractory Pemphigus Vulgaris
Christoph T. Ellebrecht, MD; Eun J. Choi, BS; David M. Allman, PhD; et al.
JAMA Dermatology
Case Report/Case Series  | 
High Anti–Desmoglein 3 Antibody ELISA Index and Negative Indirect Immunofluorescence Result in a Patient With Pemphigus Vulgaris in Remission:  Evaluation of the Antibody Profile by Newly Developed Methods
Tomoko Nakahara, MD; Atsushi Takagi, MD, PhD; Jun Yamagami, MD, PhD; et al.
JAMA Dermatology
Original Investigation  | 
Durable Remission of Pemphigus With a Fixed-Dose Rituximab Protocol
Kara Heelan, MB, BCh, BAO, MRCPI; Faisal Al-Mohammedi, MD, FRCPC; Myles J. Smith, MB, BCh, BAO, FRCSI; et al.
JAMA Dermatology
JAMA Dermatology Patient Page  | 
Pemphigus
Marcel F. Jonkman, MD, PhD